MEI Pharma Inc. (NASDAQ: MEIP) open the trading on February 19, 2021, with great promise as it jumped 9.97% to $4.19. During the day, the stock rose to $4.225 and sunk to $3.86 before settling in for the price of $3.81 at the close. Taking a more long-term approach, MEIP posted a 52-week range of $0.72-$4.57.
Meanwhile, its Annual Earning per share during the time was 15.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -113.70%. This publicly-traded company’s shares outstanding now amounts to $112.52 million, simultaneously with a float of $109.33 million. The organization now has a market capitalization sitting at $428.72 million. At the time of writing, stock’s 50-day Moving Average stood at $3.19, while the 200-day Moving Average is $3.14.
Let’s gauge the efficiency of the firm, which has a total of 51 employees. It has generated 566,922 per worker during the last fiscal year. Meanwhile, its income per employee was -902,275. The stock had 1.95 Receivables turnover and 0.20 Total Asset turnover. For the Profitability, stocks gross margin was +90.76, operating margin was -84.88 and Pretax Margin of -159.15.
MEI Pharma Inc. (MEIP) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. MEI Pharma Inc.’s current insider ownership accounts for 2.85%, in contrast to 68.70% institutional ownership.
MEI Pharma Inc. (MEIP) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 12/30/2020 suggests? It has posted -$0.1 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.13) by $0.03. This company achieved a net margin of -159.15 while generating a return on equity of -72.96. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
MEI Pharma Inc.’s EPS decrease for this current 12-month fiscal period is -113.70% and is forecasted to reach -0.48 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -0.10% through the next 5 years, which can be compared against the 15.30% growth it accomplished over the previous five years trading on the market.
MEI Pharma Inc. (NASDAQ: MEIP) Trading Performance Indicators
Let’s observe the current performance indicators for MEI Pharma Inc. (MEIP). It’s Quick Ratio in the last reported quarter now stands at 5.20. The Stock has managed to achieve an average true range (ATR) of 0.29. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 10.80. Similarly, its price to free cash flow for trailing twelve months is now 8.21.
In the same vein, MEIP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.36, a figure that is expected to reach -0.15 in the next quarter, and analysts are predicting that it will be -0.48 at the market close of one year from today.
Technical Analysis of MEI Pharma Inc. (MEIP)
[MEI Pharma Inc., MEIP] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 49.01% While, its Average True Range was 0.31.
Raw Stochastic average of MEI Pharma Inc. (MEIP) in the period of the previous 100 days is set at 81.53%, which indicates a major rise in contrast to 70.94% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 100.17% that was higher than 64.88% volatility it exhibited in the past 100-days period.